Latest Biotech News

Zealand Pharma has presented updated phase 1b clinical trial data for dapiglutide, a dual glucagon-like peptide-1 and -2 receptor agonist, which induced a mean body weight reduction of 11.6% after...

Researchers at Chuo University, led by Professor Hiroaki Suzuki, have developed a cutting-edge method for mass-producing artificial cells containing model nuclei using microfluidic technology. The...

Osaka Metropolitan University researchers have pioneered a novel technique to generate high-quality mesenchymal stem cells (MSCs) from canine induced pluripotent stem cells (iPSCs). By...

A pioneering non-destructive technique has been developed to precisely determine the depth of buried PN junctions in silicon wafers through terahertz (THz) emission spectroscopy. By stimulating...

Advancements integrating artificial intelligence with neurological diagnostics have led to the development of a fusion architecture leveraging semi-supervised speech embeddings for early detection...

The Food and Drug Administration has placed the director and deputy of its cell and gene therapy office on administrative leave, escorting both out of the agency. This sudden leadership departure,...

Researchers at the frontier of coordination and organometallic chemistry have synthesized a unique lanthanide–carbon triple bond encapsulated within an endohedral fullerene cage, specifically a...

Acute leukemias, notably acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), are aggressive hematologic malignancies characterized by dysregulated hematopoietic proliferation,...

Researchers have innovated a novel immunotherapeutic strategy enabling the in vivo generation of chimeric antigen receptor (CAR) T cells, bypassing traditional ex vivo cell manufacturing....

Scientists at Xi’an Jiaotong-Liverpool University and Nanjing University have developed a novel nanoparticle system by coassembling PLGA, a biodegradable medical polymer, with albumin, a naturally...

The FDA has approved Gilead Sciences’ lenacapavir (Yeztugo) as the first twice-yearly injection for pre-exposure prophylaxis (PrEP) against HIV. Clinical trials demonstrated nearly 100% efficacy...

A comprehensive Cochrane review encompassing 190 trials and over 7,000 stroke patients highlights virtual reality (VR) as a beneficial adjunct therapy for improving arm motor function during...

FDA Commissioner Martin Makary unveiled a pilot Commissioner’s National Priority Voucher (CNPV) program aiming to accelerate drug reviews for medicines addressing U.S. national priorities such as...

Using advanced single-nucleus RNA sequencing and chromatin accessibility assays, researchers mapped over two million nuclei from human prefrontal cortex samples from PTSD patients, depressed...

Researchers at Juntendo University have developed a novel 3D immunohistochemistry technique enhancing rapid and deep tissue imaging, significantly reducing traditional processing times. The method...

Researchers have synthesized a lanthanide–carbon triple bond encapsulated within an endohedral fullerene cage, specifically a cerium–carbide cluster [Ce≡CSc2] inside a C80 fullerene. This...

The U.S. Food and Drug Administration (FDA) announced a pilot program offering Commissioner’s National Priority Vouchers (CNPVs) that enable certain drugs addressing national health priorities to...

Gilead Sciences achieved a landmark FDA approval for lenacapavir (brand name Yeztugo), the first HIV pre-exposure prophylaxis (PrEP) drug administered twice yearly by injection. This long-acting...

A novel immunotherapy approach enables direct in vivo creation of CAR T cells using targeted lipid nanoparticles (tLNPs), bypassing complex ex vivo cell engineering processes. This strategy...

A study demonstrates that butyrate, a short-chain fatty acid produced by gut microbiota, restores abnormal sleep architecture in a Parkinson’s disease mouse model by activating the brain-derived...